Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

Foresite Capital
West HollywoodPre-Seed–Late Stage
62 people
Aju IB Invesment Corporation
SeoulSeed–Late Stage
Portfolia
San MateoSeed–Late Stage$10K
79 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
49 people
Paladin Capital Group
WashingtonSeed–Late Stage$100K – $5M
75 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
78 people
IDEA NC
DurhamPre-Seed–Late Stage$250K – $2M
3 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
36 people
Deerfield Management Company
New YorkGrowth–Late Stage
90 people
Future Planet Capital
LondonSeed–Late Stage
38 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
85 people
TA Associates
BostonGrowth–Late Stage
2 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
30 people
Summit Partners
BostonSeries B–Late Stage$10M – $500M
49 people
Speedinvest
ViennaPre-Seed–Late Stage$5M – $30M
47 people
IMM Investment Japan
SeoulSeed–Late Stage
21 people
Abstract Ventures
San FranciscoPre-Seed–Late Stage$250K – $750K
8 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
41 people
Thompson Street Capital Partners
St. LouisGrowth–Late Stage$50M – $500M
62 people
Altas Partners
TorontoGrowth–Late Stage
84 people
Birch Hill Equity Partners Management Inc.
TorontoGrowth–Late Stage$75M – $3B
74 people
Valor Equity Partners
ChicagoSeed–Late Stage
28 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage$100K – $50M
46 people
SMBC Venture Capital
TokyoPre-Seed–Late Stage$2.3M – $269M
27 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.